Bayer vs Manchester United

Bayer and Manchester United are two well-known companies that have seen fluctuations in their stock prices over the years. Bayer, a multinational pharmaceutical and life sciences company, has faced challenges ranging from legal settlements to environmental concerns. On the other hand, Manchester United, a prestigious football club, has seen its stock price affected by performance on the field and managerial changes. Investors interested in these companies should carefully consider factors such as industry trends, financial performance, and external events that may impact their stock prices.

Bayer or Manchester United?

When comparing Bayer and Manchester United, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Bayer and Manchester United.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Bayer has a dividend yield of 0.33%, while Manchester United has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Bayer reports a 5-year dividend growth of -10.74% year and a payout ratio of -9.48%. On the other hand, Manchester United reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Bayer P/E ratio at -5.16 and Manchester United's P/E ratio at -18.53. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Bayer P/B ratio is 0.18 while Manchester United's P/B ratio is 14.47.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Bayer has seen a 5-year revenue growth of 3.61%, while Manchester United's is 0.11%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Bayer's ROE at -3.68% and Manchester United's ROE at -91.24%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $7.15 for Bayer and $16.23 for Manchester United. Over the past year, Bayer's prices ranged from $6.82 to $11.51, with a yearly change of 68.77%. Manchester United's prices fluctuated between $13.50 and $22.00, with a yearly change of 62.96%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.